MODERN REVIEW: HELICOBACTER PYLORI AND RISK OF CORONARY HEART DISEASE
The article analyzes the data, foreign and the Russian literature about the relationship of Helicobacter pylori infection and the risk of cardiovascular disease. Are analyzed variations of pathogenetic mechanisms of correlation Helicobacter pylori and coronary heart disease risk. There is increasing evidence that certain microbial agents may have an etiopathogenic role in the development of atherothrombosis. Helicobacter pylori, a bacterium that causes peptic ulcer disease, has been suggested as one of the microbes involved in the development of atherothrombosis. This hypothesis is based on the following observations: a higher prevalence of Helicobacter pylori infection in patients with coronary artery disease, myocardial infarction, or cerebrovascular disease; the coincidence of Helicobacter pylori infection and cardiovascular risk factors, such as serum cholesterol and triglyceride concentrations and plasma fibrinogen; Helicobacter pylori seropositivity correlates with acute-phase proteins associated with higher risk of coronary disease, such as C-reactive protein, and controversial PCR studies indicating the presence of Helicobacter pylori in atheromas. Analysis of the scientific evidence suggests that Helicobacter pylori infection could indirectly contribute to the development and severity of atherothrombosis and cardiovascular disease. According to our opinion, are required a very large randomized studies to prove the truth of the presence of a possible connection between H. pylori and cardiovascular disease
Guseynli EG, Efremova OA, Kamyshnikova LA. Modern review: Helicobacter pylori and risk of coronary heart disease. Research Result. Medicine and Pharmacy. 2016;2(3):62-65 (In Russian). DOI: 10.18413/2313-8955-2016-2-3-3-10
While nobody left any comments to this publication.
You can be first.
10. Ayada K., Yokota K., Kobayashi K. et al. Chronic infections and atherosclerosis. Clin Rev Allergy Immunol. 2009. 37: 44—48.
11. Birnie D., Holme R., McKay I., Hood S., McColl K., Hillis W. Association between antibodies to heat shock protein 65 and coronary atherosclerosis: possible mechanism of action of Helicobacter pylori and other bacterial infections in increasing cardiovascular risk. Eur Heart J. 1998. 319: 387-94.
12. Blasi F., Denti F., Erba M., Cosentini R., Raccanelli R., Rinaldi A., et al. Detection of Chlamydia pneumoniae but not Helicobacter pylori in atherosclerotic plaques of aortic aneurysms. J Clin Microbiol 1996. 34: 2766-2775.
13. Clarke R., Daly L., Robinson K, et al. Hyperthomocysteinemia: an independent risk factor for vascular disease. N Engl J Me 1991. 324: 1149-1155.
14. El-Marshad N. еt al. Relation of Cag A-positive Helicobacter Pylori strain and some inflammatory markers in patients with ischemic heart diseases // Egypty immunol. 2009. 16 (1): 39–46.
15. Franceschi F., Niccoli G., Ferrante G. et al. CagA antigen of Helicobacter pylori and coronary instability: insight from a clinico-pathological study and a meta-analysis of 4241 cases. Atherosclerosis 2009. 202: 535-542.
16. González-Valencia G., Pérez-Pérez G., Washburn R., Blaser M. Susceptibility of Helicobacter pylori to the bactericidal activity of human serum. Helicobacter 1996. 1: 28-33.
17. Kalia N., Jacob S., Brown N., Reed M., Morton D., Bardhan K. Studies on the gastric mucosal microcirculation. Helicobacter pylori water soluble extracts induce platelet agregation in the gastric mucosal microcirculation in vivo. Gut 1997. 41: 748-52.
18. Khodaii Z. et al. Association of Helicobacter Pylori infection with acute myocardial infarction // Coron Artery Duc. 2011. Jan. 22 (1): 6–11.
19. Longo-Mbenza B. Helicobacter pylori and atherosclerosis: can current data be useful for clinical practice? Int J Cardio 2009. 135: 76-77.
20. Malfertheiner P., Megraud F., O’Morain C.A., Atherton J., Axon A.Т.R., Bazzoli F., Gensini G.F., Gisbert J.P., Graham D.Y., Rokkas T., El-Omar E.M., Kuipers E.J., The European Hylicobacter Study Group (EHSG). Management of Helicobacter pylori infection - the Maastricht—IV/Florence Consensus Report. Gut 2012. 61: 646-664.
21. May K. Ismael, Mahmood R. Al-Haleem, Rawaa S. Salman Evaluation of Anti-Helicobacter pylori Antibodies in A group of Iraqi Patients with Atherosclerosis and Coronary Artery Disease. Iraqi Journal of Science. 2015. Vol 56, N.1A: 81-88.
22. Monaco C. et al. Persistent systemic inflammation in unstable angina is largely unrelated to the atherothrombotic burden // J. Am. Coll. Cardiol. 2005. Vol. 45 (2): 238-243.
23. NiemeläS., Karttunen T., Korhonen T., Läärä E., Karttunen R., Ikäheino M., et al. Could Helicobacter pylori infection increase the risk of coronary heart disease by modifying serum lipid concentrations? Heart 1996. 75: 573-578.
24. Oshima T. et. al. Association of Helicobacter pylori infection with systemic inflammation and endothelial dysfunction in healthy male subjects // J.Am. Coll. Card. 2005. Vol. 45: 1219-1222.
25. Patel P., Carrington D., Strachan D., Leatham E., Goggin P., Northfield T., et al. Fibrinogen: a link between chronic infection and coronary heart disease. Lancet 1994;343:1634-5.
26. Pattis I. et al. The Helicobacter pylori CagF protein is a type IV secretion chaperone-like molecule that binds close to the C-terminal secretion signal of theCagA effector protein // Microbiology. 2007. Vol. 153: 2896–2909.
27. Pellicano R. et al. Helicobacter pylori and coronary heart disease: which directions for future studies? // Crit. Rev. Microbiol. 2003. Vol. 29 (4): 351-359.
28. Rasmi Y., Raeisi S. Possible role of Helicobacter pylori infection via microvascular dysfunction in cardiac syndrome X // Cardiol. J. 2009. Vol. 16, N 6: 585–587.
29. Regnström J., Jovinge S., Bavenholm P., Ericson C., De Faire U., Hamsten A., et al. Helicobacter pylori seropositivity is not associated with inflammatory parameters, lipid concentrations and degree of coronary artery disease. J Int Med 1998. 243:109-1022.
30. Umreda M. et al. Helicobacter pylori CagA causes mitotic impairment and induces chromosomal instability // J. Biol. Chem. 2009. Vol. 284, N 33: 22166–22172.
31. Weydig C. et al. CagA-independent disruption of adherence junction complexes involves E-cadherin shedding and implies multiple steps in Helicobacter pylori pathogenicity // Exp. Cell. Res. 2007. Vol. 313, N 16: 3459-3471.